UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 4, 2003 HEALTHEXTRAS, INC. ------------------ (Exact name of registrant as specified in its charter) Delaware 0-31014 52-2181356 ------------------------------ ---------- ------------- (State or other Jurisdiction of (Commission (IRS Employer incorporation) File Number) Identification No.) 2273 Research Boulevard, 2nd Floor, Rockville, Maryland 20850 ------------------------------------------------------------- (Address of principal executive offices) (301) 548-2900 -------------- (Registrant's telephone number, including area code) Not Applicable -------------- (Former name or former address, if changed since last report.) ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (a) Financial statements of business acquired: Not Applicable (b) Pro forma financial information: Not Applicable (c) Exhibits: Exhibit No. Description ----------- ----------- 99.1 Press Release Dated February 4, 2003 ITEM 9. REGULATION FD DISCLOSURE. Attached hereto as Exhibit 99.1 is HealthExtras, Inc. Press Release dated February 4, 2003 announcing fourth quarter and year end-financial results. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 4, 2003 By: /s/ Michael P. Donovan --------------------------- Michael P. Donovan Chief Financial Officer and Chief Accounting Officer